BELLICUM PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
-2.31% | -53.99% |
Volumes
marketsCapital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (EUR)
822 121
Capitalization (USD)
822 121
Net sales ()
1 500 000
Number of employees
13
Sales / Employee (USD)
115 385
Free-Float
98.45 %
Free-Float capitalization (EUR)
791 903
Free-Float capitalization (USD)
791 903
Highs and lows
Current year
0.00
0.13
1 year
0.000.19
3 years
0.000.19
5 years
0.000.19
10 years
0.000.19
Indicators
Moving average 5 days
0.07
Moving average 20 days
0.07
Moving average 50 days
0.09
Moving average 100 days
0.11
RSI 9 days
42.68
RSI 14 days
42.33
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -.--% | -2.31% | - | - | 822K | ||
| -0.69% | +2.99% | +20.12% | +41.23% | 127B | ||
| +1.83% | +6.36% | +25.25% | +53.12% | 117B | ||
| +0.33% | +7.10% | +25.56% | +27.45% | 27.77B | ||
| +0.30% | +6.07% | -19.51% | -22.06% | 20.44B | ||
| +2.64% | +6.19% | -14.36% | -27.88% | 16.62B | ||
| +1.11% | +3.49% | -15.63% | -20.77% | 15.92B | ||
| -0.05% | +2.05% | -46.67% | -38.80% | 14.94B | ||
| +0.63% | +6.00% | +11.89% | +51.63% | 14.74B | ||
| 0.00% | +0.25% | +57.74% | +40.86% | 14.38B | ||
| -0.42% | +9.59% | +147.53% | +277.70% | 12.42B | ||
| -0.32% | -1.49% | +147.72% | +302.66% | 9.55B | ||
| +0.52% | +5.91% | +31.19% | +72.11% | 8.92B | ||
| +12.10% | +17.43% | -9.64% | -21.92% | 8.84B | ||
| +1.75% | +1.67% | +9.63% | +59.52% | 7.78B | ||
| -1.80% | -1.59% | -4.93% | +32.60% | 7.48B | ||
| Average | +1.12% | +4.69% | +24.39% | +55.16% | ||
| Weighted average by Cap. | +0.74% | +5.20% | +21.50% | +45.37% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -53.99% | ||
| 2023 | +20.00% |
- Stock Market
- Equities
- BPXA Stock
- Quotes Bellicum Pharmaceuticals, Inc.
